EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Transforming Obesity Care With Digital Therapeutics: Mobile Health Apps, Clinical Evidence, and Regulatory Considerations

Mayuri iD, Bidisha Bhattacharya iD, Kunal Kar iD, Pravin Pawar iD, Inderbir Singh iD, Tanikan Sangnim iD, Kampanart Huanbutta iD

Journal of Obesity · 2026

DOI: 10.1155/jobe/9482093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Obesity, 2026. Verfasst von Mayuri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India, chitkara.edu.in. Hauptthemen laut MEDLINE: Mobile Applications, Obesity. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity remains a complex global public health crisis driven by environmental, biochemical, and behavioral factors, leading to severe metabolic comorbidities. Digital therapeutics (DTx) has emerged as a scalable, data‐driven intervention, utilizing wearable sensors, mobile applications, and artificial intelligence (AI) to deliver personalized weight‐management strategies. Rather than relying solely on traditional approaches, true DTx distinguishes it through rigorous clinical validation and targeted behavioral modification. Current evidence from clinical trials and real‐world data indicates that while DTx effectively enhances patient engagement and promotes short‐term behavioral change, sustaining long‐term adherence and significant weight loss remains a critical challenge. Furthermore, the integration of AI models offers advanced personalization, though their efficacy must be balanced against potential algorithmic biases and traditional statistical approaches. Successful implementation of DTx into standard obesity care requires overcoming substantial barriers, particularly digital divide, data privacy concerns, and fragmented regulatory frameworks. Ultimately, realizing the full potential of DTx necessitates collaborative efforts to establish standardized regulations, ensure equitable access, and design evidence‐based interventions that prioritize long‐term patient engagement and clinical efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mobile ApplicationsObesityHumansDigital HealthArtificial IntelligenceTelemedicineWearable Electronic Devices

Stichwörter der Autor:innen

artificial intelligencedigital therapeuticsmobile applicationsobesity managementsoftware as a medical device

Autor:innen und Institutionen

  • Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India, chitkara.edu.in.
  • Dr. Shivajirao Kadam College of Pharmacy, Sangli, Maharashtra, India.
  • Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, 20131, Thailand, buu.ac.th.
  • Department of Manufacturing Pharmacy, College of Pharmacy, Rangsit University, Pathum Thani, 12000, Thailand, rsu.ac.th.

ORCID-Profile: Mayuri, Bidisha Bhattacharya, Kunal Kar, Pravin Pawar, Inderbir Singh, Tanikan Sangnim, Kampanart Huanbutta

Zitieren

APA

Mayuri, Bhattacharya, B., Kar, K., Pawar, P., Singh, I., Sangnim, T., & Huanbutta, K. (2026). Transforming Obesity Care With Digital Therapeutics: Mobile Health Apps, Clinical Evidence, and Regulatory Considerations. Journal of Obesity. https://doi.org/10.1155/jobe/9482093

Vancouver

Mayuri, Bhattacharya B, Kar K, Pawar P, Singh I, Sangnim T, et al. Transforming Obesity Care With Digital Therapeutics: Mobile Health Apps, Clinical Evidence, and Regulatory Considerations. Journal of Obesity. 2026. doi:10.1155/jobe/9482093

BibTeX
@article{Mayuri2026,
  author = {Mayuri and Bhattacharya, Bidisha and Kar, Kunal and Pawar, Pravin and Singh, Inderbir and Sangnim, Tanikan and Huanbutta, Kampanart},
  title = {Transforming Obesity Care With Digital Therapeutics: Mobile Health Apps, Clinical Evidence, and Regulatory Considerations},
  journal = {Journal of Obesity},
  year = {2026},
  doi = {10.1155/jobe/9482093}
}
Kostenlos starten →